7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 7 of 7 clinical reviews.
A clinical deep-dive into Adderall XR (mixed amphetamine salts) pharmacogenomics, cardiovascular considerations, and dosing guidance specific to Black and African ancestry patients, reviewed by the HealthRX.com medical team.
A clinical deep-dive into pharmacogenomic, cardiovascular, and trial-level evidence for Adderall XR efficacy differences in Black and African ancestry patients, with dosing and monitoring guidance.
A clinician-reviewed guide to Adderall XR dosing in East Asian patients, covering CYP2D6 and CYP2C19 polymorphism rates, ethnicity-stratified pharmacokinetic data, and practical dose-titration strategies.
A clinician-focused guide to Adderall XR (mixed amphetamine salts) dosing in Hispanic and Latino patients, covering CYP2D6 pharmacogenomics, comorbidity burden, ethnicity-stratified trial data, and practical titration strategies reviewed by the HealthRX medical team.
How CYP2D6 variants, metabolic comorbidities, and pharmacogenomic data shape Adderall XR safety considerations for Hispanic and Latino patients.
A clinical deep-dive into pharmacogenomic, metabolic, and trial-representation factors that may alter Adderall XR efficacy in Hispanic and Latino patients with ADHD, including CYP2D6 variants, obesity phenotypes, and dosing considerations.
Evidence-based review of how CYP2D6 polymorphisms, cardiovascular risk thresholds, and trial underrepresentation affect Adderall XR efficacy and safety in South Asian populations.